Table 6 Clinical, hormonal, and radiological findings in all patients who developed AVP deficiency after COVID-19 infection
Reference | Gender | Age | Onset Days until COVID-19 diagnosis | Patient back ground | Serum sodium at AVP-D onset | Anterior pituitary hormonal disorders and co-exsisting disease | Pituitary MRI |
|---|---|---|---|---|---|---|---|
Rajevac et al. [5] | M | 68 | 23 days | Inpatient(intubation) | Hypernatremia | N | No findings |
Sheikh et al. [6] | F | 44 | 12 days | Inpatient | Hypernatremia | Secondary adrenal insufficiency | No findings |
Misgar et al. [7] | F | 60 | 8 weeks | Outpatient | Hypernatremia | N | Thickened pituitary stalk |
Sheikh et al. [8] | M | 28 | 4 weeks | Inpatient | Hypernatremia | Myocarditis | No findings |
Yavari et al. [9] | F | 54 | 6 weeks | Outpatient | Normonatremia | N | No findings |
Lizzi et al. [10] | M | 17 | 3 weeks | Outpatient | Hypernatremia | N | Absent posterior pituitary hyperintensity |
Suresh et al. [11] | M | 35 | 12 days | Outpatient | Hyponatremia | Transient AVP deficiency | Not done |